Evidence map›Paper›PMID 36076181›Full record

ArticleBMC pediatrics2022

Caregiver perceptions of in-home COVID-19 testing for children with medical complexity: a qualitative study.

Anna Jolliff, Nicole E Werner, Hanna J Barton, Kristina Devi Howell, Michelle M Kelly, Makenzie Morgen, Mary Ehlenbach, Gemma Warner, Barbara Katz, Madeline Kieren and 2 more

Abstract read
In one paragraph

Article in BMC pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. "Frontiers in pediatrics · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anna JolliffDepartment of Health and Wellness Design, Indiana University School of Public Health-Bloomington, 1025 E 7th St, Bloomington, IN, 47405, USA. annjoll@iu.edu.
Nicole E WernerDepartment of Health and Wellness Design, Indiana University School of Public Health-Bloomington, 1025 E 7th St, Bloomington, IN, 47405, USA.
Hanna J BartonDepartment of Industrial and Systems Engineering, University of Wisconsin - Madison, 1550 Engineering Drive, Madison, WI, 53706, USA.
Kristina Devi HowellDepartment of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA.
Michelle M KellyDepartment of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA.
Makenzie MorgenDepartment of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA.
Mary EhlenbachDepartment of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA.
Gemma WarnerDepartment of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA.
Barbara KatzFamily Voices of Wisconsin, Madison, WI, USA.
Madeline KierenDepartment of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA.
Gregory DeMuriDepartment of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA.
Ryan J CollerDepartment of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA.

Funding

University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
ReSET: Restarting Safe Education and Testing for Children with Medical ComplexityOT2HD107558 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI COLLER, RYAN J, DEMURI, GREGORY P · 2021 to 2022
$3.0M
NCATS NIH HHS UL1 TR002373NICHD NIH HHS OT2 HD107558
6 · The paper itself

Abstract

backgroundIn-home direct antigen rapid testing (DART) plays a major role in COVID-19 mitigation and policy. However, perceptions of DART within high-risk, intellectually impaired child populations are unknown. This lack of research could negatively influence DART uptake and utility among those who stand to benefit most from DART. The purpose of this study was to describe caregivers' perceptions of an in-home COVID-19 DART regimen in children with medical complexity, including the benefits and limitations of DART use.

methodsThis qualitative study was a subproject of the NIH Rapid Acceleration of Diagnostics Underserved Populations research program at the University of Wisconsin. We combined survey data and the thematic analysis of semi-structured interview data to understand caregivers' perceptions of in-home COVID-19 testing and motivators to perform testing. Caregivers of children with medical complexity were recruited from the Pediatric Complex Care Program at the University of Wisconsin (PCCP). Data were collected between May and August 2021.

resultsAmong n = 20 caregivers, 16/20 (80%) of their children had neurologic conditions and 12/20 (60%) used home oxygen. Survey data revealed that the largest caregiver motivators to test their child were to get early treatment if positive (18/20 [90%] of respondents agreed) and to let the child's school know if the child was safe to attend (17/20 [85%] agreed). Demotivators to testing included that the child could still get COVID-19 later (7/20 [35%] agreed), and the need for officials to reach out to close contacts (6/20 [30%] agreed). From interview data, four overarching themes described perceptions of in-home COVID-19 testing: Caregivers perceived DART on a spectrum of 1) benign to traumatic and 2) simple to complex. Caregivers varied in the 3) extent to which DART contributed to their peace of mind and 4) implications of test results for their child.

conclusionsAlthough participants often described DART as easy to administer and contributing to peace of mind, they also faced critical challenges and limitations using DART. Future research should investigate how to minimize the complexity of DART within high-risk populations, while leveraging DART to facilitate safe school attendance for children with medical complexity and reduce caregiver burden.

Indexed as

CaregiversCOVID-19ChildCOVID-19 TestingFamilyHumansQualitative ResearchChildren with medical complexityCOVID-19Direct antigen rapid testing

Identifiers

PMID36076181
PMCPMC9452877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.